Delivery Order SPE2DX15D6028-SPE2DX24FWPGR
Award Date
6/3/24
Potential Completion Date
6/4/24
Potential Value
$2.9K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $39,439.89 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. This contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,713.85 firm fixed price delivery order is for the supply of Activase 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,864.71 Firm Fixed Price Delivery Order is for the supply of ACTIVASE 50 MG VIALS, a critical pharmaceutical product, with a period of performance through May 28, 2024. The award is not associated with any set-aside designations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,141.52 Firm Fixed Price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical medical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $23,241.52 by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense, with a potential value...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,702.05 firm-fixed-price delivery order is for the supply of 100 mg vials of the drug ACTIVASE, with a period of performance through November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, to the U.S. government. The contract, with a ceiling value of $5,779.78, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the Department of Defense (DoD). The contract does not have a set-aside designation and is a Firm Fixed Price agreement with an ultimate completion date of...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $2,977.39 firm-fixed-price delivery order is for the supply of 50 mg vials of the pharmaceutical product Activase. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTIVASE 100 MG VIALS. The contract has a potential value of $17,676.17 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. This delivery order is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,427.70 Firm Fixed Price delivery order is for the supply of ACTIVASE 100 MG vials, a critical cardiovascular medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...